BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $302,109 | -17.2% | 8,005 | 0.0% | 0.02% | -11.8% |
| Q2 2023 | $364,708 | +9.6% | 8,005 | -2.4% | 0.02% | 0.0% |
| Q1 2023 | $332,795 | -20.4% | 8,205 | 0.0% | 0.02% | -22.7% |
| Q4 2022 | $418,209 | -24.8% | 8,205 | -20.5% | 0.02% | -29.0% |
| Q3 2022 | $556,000 | -17.0% | 10,325 | -1.0% | 0.03% | -11.4% |
| Q2 2022 | $670,000 | -23.5% | 10,425 | -7.8% | 0.04% | -7.9% |
| Q1 2022 | $876,000 | -12.1% | 11,301 | -2.7% | 0.04% | -5.0% |
| Q4 2021 | $997,000 | +5.4% | 11,612 | -1.3% | 0.04% | 0.0% |
| Q3 2021 | $946,000 | -1.6% | 11,762 | -1.5% | 0.04% | 0.0% |
| Q2 2021 | $961,000 | -10.0% | 11,943 | -5.7% | 0.04% | -16.7% |
| Q1 2021 | $1,068,000 | +5.1% | 12,668 | 0.0% | 0.05% | +4.3% |
| Q4 2020 | $1,016,000 | -1.5% | 12,668 | -1.2% | 0.05% | -9.8% |
| Q3 2020 | $1,031,000 | -6.6% | 12,818 | 0.0% | 0.05% | -15.0% |
| Q2 2020 | $1,104,000 | +3.9% | 12,818 | -2.1% | 0.06% | -13.0% |
| Q1 2020 | $1,063,000 | -23.9% | 13,088 | -21.6% | 0.07% | -1.4% |
| Q4 2019 | $1,396,000 | -4.4% | 16,696 | 0.0% | 0.07% | -9.1% |
| Q3 2019 | $1,460,000 | +2.3% | 16,696 | -4.2% | 0.08% | +4.1% |
| Q2 2019 | $1,427,000 | -3.1% | 17,421 | -3.8% | 0.07% | -6.3% |
| Q1 2019 | $1,472,000 | +22.2% | 18,104 | -1.1% | 0.08% | +54.9% |
| Q4 2018 | $1,205,000 | -24.5% | 18,304 | -11.6% | 0.05% | -10.5% |
| Q3 2018 | $1,596,000 | -49.5% | 20,709 | -51.6% | 0.06% | -52.5% |
| Q2 2018 | $3,161,000 | +9.8% | 42,814 | -3.3% | 0.12% | +9.1% |
| Q1 2018 | $2,878,000 | +0.6% | 44,254 | 0.0% | 0.11% | +4.8% |
| Q4 2017 | $2,861,000 | -0.1% | 44,254 | -3.0% | 0.10% | -4.5% |
| Q3 2017 | $2,863,000 | +9.7% | 45,624 | +5.8% | 0.11% | +7.8% |
| Q2 2017 | $2,611,000 | +16.8% | 43,121 | 0.0% | 0.10% | +12.1% |
| Q1 2017 | $2,236,000 | +15.2% | 43,121 | -1.5% | 0.09% | +7.1% |
| Q4 2016 | $1,941,000 | -25.9% | 43,781 | -20.4% | 0.08% | -29.8% |
| Q3 2016 | $2,620,000 | +3.9% | 55,035 | -1.3% | 0.12% | +2.5% |
| Q2 2016 | $2,522,000 | +5.7% | 55,775 | -4.0% | 0.12% | -0.8% |
| Q1 2016 | $2,386,000 | +3.6% | 58,072 | -3.8% | 0.12% | +4.4% |
| Q4 2015 | $2,303,000 | +13.7% | 60,357 | -2.1% | 0.11% | +14.0% |
| Q3 2015 | $2,025,000 | -66.1% | 61,632 | -27.9% | 0.10% | -62.5% |
| Q2 2015 | $5,977,000 | +35.7% | 85,467 | +32.9% | 0.27% | +36.9% |
| Q1 2015 | $4,406,000 | -24.6% | 64,327 | -19.3% | 0.20% | -25.0% |
| Q4 2014 | $5,842,000 | +29.3% | 79,712 | +26.7% | 0.26% | +32.0% |
| Q3 2014 | $4,517,000 | -4.1% | 62,934 | -3.4% | 0.20% | -1.5% |
| Q2 2014 | $4,709,000 | -4.7% | 65,134 | -3.0% | 0.20% | -9.9% |
| Q1 2014 | $4,942,000 | -18.9% | 67,159 | -23.4% | 0.22% | +1.8% |
| Q4 2013 | $6,096,000 | +5.3% | 87,649 | -0.5% | 0.22% | -4.0% |
| Q3 2013 | $5,788,000 | -20.2% | 88,104 | -15.9% | 0.23% | -12.7% |
| Q2 2013 | $7,256,000 | – | 104,749 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |